|
|
||||||||
1 Departments of Reproductive Biology and Nutrition, Case Western Reserve University School of Medicine at MetroHealth Medical Center, Cleveland, Ohio 44109; and 2 Noll Physiological Research Center and the General Clinical Research Center, Pennsylvania State University, University Park, Pennsylvania 16802
| |
ABSTRACT |
|---|
|
|
|---|
Insulin action in skeletal muscle is enhanced by regular
exercise. Whether insulin signaling in human skeletal muscle is
affected by habitual exercise is not well understood.
Phosphatidylinositol 3-kinase (PI3-kinase) activation is an important
step in the insulin-signaling pathway and appears to regulate glucose
metabolism via GLUT-4 translocation in skeletal muscle. To examine the
effects of regular exercise on PI3-kinase activation, 2-h
hyperinsulinemic (40 mU · m
2 · min
1)-euglycemic
(5.0 mM) clamps were performed on eight healthy exercise-trained [24 ± 1 yr, 71.8 ± 2.0 kg, maximal O2 uptake
(
O2 max) of 56.1 ± 2.5 ml · kg
1 · min
1]
and eight healthy sedentary men and women (24 ± 1 yr, 64.7 ± 4.4 kg,
O2 max of
44.4 ± 2.7 ml · kg
1 · min
1).
A [6,6-2H]glucose tracer was used to measure
hepatic glucose output. A muscle biopsy was obtained from the vastus
lateralis muscle at basal and at 2 h of hyperinsulinemia to measure
insulin receptor substrate-1(IRS-1)-associated PI3-kinase activation.
Insulin concentrations during hyperinsulinemia were similar for both
groups (293 ± 22 and 311 ± 22 pM for trained and sedentary,
respectively). Insulin-mediated glucose disposal rates (GDR) were
greater (P < 0.05) in the exercise-trained compared with the
sedentary control group (9.22 ± 0.95 vs. 6.36 ± 0.57 mg · kg fat-free
mass
1 · min
1).
Insulin-stimulated PI3-kinase activation was also greater (P < 0.004) in the trained compared with the sedentary group (3.8 ± 0.5- vs. 1.8 ± 0.2-fold increase from basal). Endurance capacity (
O2 max)
was positively correlated with PI3-kinase activation (r = 0.53, P < 0.04). There was no correlation between PI3-kinase and
muscle morphology. However, increases in GDR were positively related to
PI3-kinase activation (r = 0.60, P < 0.02). We
conclude that regular exercise leads to greater insulin-stimulated
IRS-1-associated PI3-kinase activation in human skeletal muscle, thus
facilitating enhanced insulin-mediated glucose uptake.
glucose metabolism; exercise training; insulin action; muscle; enzymes; insulin receptor substrate-1; phosphatidylinositol 3-kinase
| |
INTRODUCTION |
|---|
|
|
|---|
EXERCISE HAS LONG BEEN USED to successfully treat and prevent insulin resistance and Type 2 diabetes. Nevertheless, our knowledge of the mechanisms that explain how exercise training improves insulin-mediated glucose regulation remains unclear. A number of investigators have shown increased skeletal muscle insulin sensitivity among people who exercise on a regular basis (14, 26, 29, 34). Mechanisms that have been proposed to account for these exercise-related improvements include prereceptor events [increased blood flow (14) and muscle fiber morphology, as well as postreceptor adaptations], increased glucose transport and concentration of GLUT-4 glucose transporters in skeletal muscle (11, 17, 22), and greater activity of the enzymes hexokinase II (30) and glycogen synthase (13, 14). Recently, investigators have successfully identified postreceptor steps that include an intracellular insulin-signaling cascade that leads to cellular glucose uptake in skeletal muscle (6, 7, 31, 39, 42). To date, there has been little elucidation on the effects of exercise training on insulin signaling in human skeletal muscle at the molecular level and the contribution that such effects might have on glucose metabolism.
In skeletal muscle, insulin binds to its receptor on the plasma membrane and initiates a pleiotrophic cascade of intracellular signaling events that includes increased glucose uptake via the recruitment of a pool of intracellular glucose transporters known as GLUT-4 (19). The proximal steps in this signaling cascade involve autophosphorylation of the insulin receptor on tyrosine residues, phosphorylation of a family of substrates that includes insulin receptor substrate-1 (IRS-1) (39), and subsequent binding and activation of phosphatidylinositol 3-kinase (PI3-kinase). There is now ample evidence to demonstrate the involvement of PI3-kinase in the process of skeletal muscle glucose uptake (6, 7, 31, 42).
If the increased insulin sensitivity associated with exercise training is a postreceptor adaptation, it may be mediated by enhanced intracellular signaling leading to greater glucose uptake by the muscle. An increase in insulin-stimulated PI3-kinase activation in exercise-trained muscle could provide important information on the effects of exercise on the insulin signaling pathway and reveal new clues regarding the mechanisms responsible for the augmented insulin sensitivity that is observed among exercise-trained individuals. Therefore, the purpose of this study was to determine whether insulin-stimulated PI3-kinase activation in skeletal muscle is upregulated in men and women who exercise on a regular basis. In addition, we evaluated whether alterations in insulin-activated PI3-kinase with regular exercise are associated with enhanced insulin-mediated glucose uptake. Because muscle fiber morphology and increased perfusion of skeletal muscle have been considered as possible prereceptor adaptations that facilitate enhanced insulin action after exercise training, we also examined the relationship between insulin activation of PI3-kinase, skeletal muscle fiber composition, and capillary density in exercise-trained and sedentary subjects.
| |
METHODS |
|---|
|
|
|---|
Subjects
Eight exercise-trained men (n = 7) and women (n = 1) and eight sedentary men (n = 6) and women (n = 2) participated in the study (Table 1). All of the subjects in the trained group had engaged in aerobic exercise (running and/or cycling) 4-5 days/wk for at least 12 mo before the study. All subjects were requested to perform a "normal" workout (45-90 min, at ~80-90% maximal heart rate) no later than midafternoon on the day preceding the procedure. The study was approved by the Institutional Review Board for Human Subjects, and all volunteers signed an informed consent in accordance with Pennsylvania State University guidelines for the protection of human subjects.
|
Each subject performed an incremental treadmill test to determine
maximal oxygen consumption
(
O2 max). Inspired
air volumes were measured from pressure changes detected with a
pneumotach (Hans Rudolph). Concentrations of O2 and
CO2 were measured on an electrochemical O2
analyzer (Applied Electrochemistry, S-3A) and infrared CO2
analyzer (Beckman LB-2), respectively. A standard 75-g oral glucose
tolerance test was performed to verify normal glucose tolerance (2).
Body density was determined by hydrostatic weighing after an overnight
fast according to the method of Akers and Buskirk (1). Underwater
weight was determined using electronic load cells. Residual lung volume
was determined during immersion by open-circuit nitrogen washout, and
percent body fat was estimated using the Siri equation (37). Height was
measured to the nearest 1.0 cm without shoes, and body weight was
measured to the nearest 0.1 kg. To control dietary intake and physical
activity, subjects ate their evening meal in the General Clinical
Research Center and stayed overnight before the experimental protocol.
The subjects were instructed to consume a diet that consisted of 60%
of energy coming from carbohydrate, 25% from fat, and 15% from
protein for the 2 days before the trial.
Experimental Protocol
Hyperinsulinemic-euglycemic clamps (120 min, 40 mU · m
2 · min
1
insulin and 5.0 mM glucose) were performed as originally described by
DeFronzo et al. (9). After a 10- to 12-h overnight fast and ~18 h
after the last exercise bout (trained only), the subjects voided
morning urine and were weighed. A polyethylene catheter was inserted
into an antecubital vein for infusion of insulin, glucose,
[6,6-2H]glucose, and potassium chloride. A
second polyethylene catheter was inserted retrograde into a dorsal hand
vein, and the hand was warmed in a heated box (~65°C) for
sampling of arterialized venous blood (33). Hepatic glucose output was
measured using a bolus (3.276 mg/kg) infusion (Harvard Apparatus, South
Natick, MA) of [6,6-2H]glucose (Tracer
Technology, Somerville, MA) followed by a constant infusion at 0.0364 mg · kg
1 · min
1
for a 2-h baseline period and throughout the clamp. After the baseline
period, a primed, continuous infusion (40 mU · m
2 · min
1)
of human insulin (Humulin, Eli Lilly, Indianapolis, IN) was initiated
and maintained for a period of 2 h. Baseline blood samples were drawn
before the tracer infusion and at 10-min intervals during the last 30 min of the baseline period and the last 40 min of the hyperinsulinemic
clamp. Plasma glucose levels were clamped at 5.0 mM during
hyperinsulinemia by use of a variable glucose infusion (20% dextrose).
Blood samples for plasma glucose and insulin determination were drawn
at 5- and 15-min intervals, respectively, during the clamp. Muscle
biopsies were performed using the needle biopsy procedure as previously
described (28). Tissue was obtained from the vastus lateralis muscle of
one leg during the baseline period and from the opposite leg
immediately at the 120-min time point of the clamp. Hyperinsulinemia
was maintained throughout the biopsy procedure.
Analytical Procedures
Plasma glucose concentrations were measured by the glucose oxidase method (Beckman Instruments, Fullerton, CA). Blood samples for insulin measurements were centrifuged at 4°C, and the plasma was stored at
70°C for subsequent analysis in duplicate by a double-antibody RIA (Linco Research, St. Charles, MO).
Blood samples for [6,6-2H]glucose determination were prepared as described previously (27). The samples were centrifuged, and the plasma (200 µl) was deproteinized with 300 µl of cold acetone. After further centrifugation, the supernatant was removed and evaporated and the pentaacetate derivative of glucose was formed by addition of 100 µl of acetic anhydride-pyridine (1:1). Glucose was separated at 180°C on a 3% OV column, and its 2H isotopic abundance was measured by positive ion-chemical ionization mass spectrometry through the use of selective ion monitoring of mass-to-charge ratios of 333 and 331.
Muscle analysis.
The muscle sample was immediately homogenized in a buffer solution (50 mM HEPES, 137 mM NaCl, 1 mM MgCl2, 1 mM CaCl2,
10 mM sodium pyrophosphate, 10 mM NaF, 2 mM EDTA, 2 mM
NaVO4, 1% NP-40, 10% glycerol, 2 µg/ml aprotinin, 5 µg/ml leupeptin, 1.5 mg/ml bentamidine, 0.2 M
4-(2-aminoethyl)benzenesulfonyl fluoride, 10 µg/ml
antipain, and 0.5 µg/ml pepstatin) for subsequent analysis of
IRS-1-associated PI3-kinase activation. A second sample was prepared
for histochemical analysis of muscle fiber type and capillary density.
The muscle sample was mounted in tragacanth gum and quickly frozen in
isopentane, cooled in liquid N2. All muscle specimens for
histochemical analysis were stored at
70°C. A total of 15 serial cross sections (10 µm) of each muscle specimen were cut at
20°C in a cryostat microtome (Leica Cryocut 1800) and
mounted on slides. The sections were dried at room temperature and
stained for myosin ATPase (preincubation at pH 4.3 and 4.6) and with
amylase-periodic acid-Schiff to visualize capillaries (3).
An average of 300 muscle fibers were identified as type I and II based
on the ATPase stain. Capillary counts were expressed as capillaries per fiber.
IRS-1-associated PI3-kinase activity.
Protein concentration in the tissue homogenates was determined by the
Bio-Rad protein assay following the manufacturer's instructions (Bio-Rad Laboratories). A 1-mg sample of total protein was
immunoprecipitated with 4 µg of the IRS-1 polyclonal antibody
(Upstate Biotechnology, Lake Placid, NY) and rocked overnight at
4°C. A 40-µl sample of slurry protein A-Sepharose was added to
the immunoprecipitate for 2 h, and an immunocomplex was obtained by
brief centrifugation at 9,000 rpm and washed three times in PBS-1%
NP-40, twice in 500 mM LiCl-100 mM Tris (pH 7.6), and once in 10 mM
Tris · HCl (pH 7.4), 100 mM NaCl, and 1 mM CDTA. The
pellet was centrifuged one more time and washed in PI3-kinase adenosine
assay buffer [20 mM Tris (pH 7.4), 100 mM NaCl, 10 mM
MgCl2, 0.5 mM EGTA, and 120 µM adenosine]. The
final pellet was resuspended in 40 µl of PI3-kinase adenosine assay
buffer. A 50-µl sample of phosphatidylinositol and phosphatidylserine
was dried down in a nitrogen stream and sonicated in 100 µl of 20 mM
HEPES-1 mM EDTA (pH 7.4). The lipid mixture was kept on ice, and 5 µl
of this mixture (2 µg/µl of phosphatidylinositol) were added to
each sample. The solution was mixed by sonication and incubated for 10 min at 30°C on a heat block. A mixture consisting of 170 µCi of
-32P-labeled and 280 µM unlabeled ATP was prepared,
and the reaction was started by adding 5 µl of this mixture into each
sample. After 10 min at 30°C, the reaction was stopped by the
addition of 200 µl of 1 N HCl to each sample. The
phosphatidylinositol 3-phosphate (PI3-phosphate) was extracted with 160 µl chloroform-methanol (1:1). The phases were separated by
centrifugation, and the lower organic phase was removed and separated
by TLC. The radioactivity incorporated into PI3-phosphate was
determined by PhosphorImaging (Molecular Dynamics, Sunnyvale, CA).
Calculations and Statistical Analysis
The rates of glucose appearance and disappearance (Rd) were calculated from plasma [6,6-2H]glucose enrichments and the rate of tracer infusion, using the equations described by Jahoor et al. (23). When Rd was estimated as a negative value, the glucose disposal rate was assumed to be the steady-state glucose infusion rate. All values are presented as means ± SE. Differences between dependent variables were examined with two-way ANOVA. Differences between descriptive variables were examined with a one-way ANOVA. Specific mean differences were identified with a Newman-Keuls post hoc test. The
-level for statistical significance
was set at 0.05.
| |
RESULTS |
|---|
|
|
|---|
Subjects were similar in age and body composition, but the trained group had a higher maximal exercise oxygen consumption compared with the sedentary group (Table 1). Muscle fiber types (51 ± 7 vs. 35 ± 7% type I, P = 0.06, for the trained and untrained subjects, respectively) and capillary density (2.8 ± 0.4 vs. 1.8 ± 0.1 capillaries/fiber, P = 0.07, for the trained and sedentary subjects, respectively) were not significantly different between the groups.
Fasting glucose and insulin levels were normal and were similar for
both groups of subjects before the initiation of the glucose clamp
(Table 2). Mean glucose concentrations were
5.1 ± 0.1 and 4.9 ± 0.1 mM for the trained and sedentary groups
during the final 30 min (90-120 min) of the clamp (Table 2). The
coefficients of variation for plasma glucose during this period were
5.6 ± 0.7% and 4.8 ± 0.5% for the trained and sedentary groups,
respectively (Table 2). Insulin-mediated glucose disposal rates
expressed per kilogram fat-free mass were significantly higher in the
exercise-trained group compared with the untrained, sedentary group
(Fig. 1).
|
|
Insulin activation of IRS-1-associated PI3-kinase was expressed as
multiples of increase in activity measured in the muscle during hyperinsulinemia (120 min) with respect to the preclamp muscle
sample. Activation was significantly increased in both the trained
(P < 0.0001) and sedentary (P < 0.003) groups as a result of hyperinsulinemia (Fig. 2). The
level of activation was significantly greater (P < 0.004) in
the trained group compared with the sedentary control group. All of the
trained subjects showed an increase in activation, seven of the
untrained subjects showed an increase, and one showed no change.
Correlation analysis revealed a significant positive relationship
(r = 0.60, P < 0.02) between glucose disposal rates
and PI3-kinase activation (Fig. 3).
PI3-kinase activation was also significantly related to
O2 max (r = 0.53, P < 0.04). There was no correlation between PI3-kinase activation and capillary density (r = 0.04, P = 0.93)
or glucose disposal rate and capillary density (r = 0.51, P = 0.16).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
In the present study, we examined the role that regular exercise plays
in altering the regulation of insulin-mediated glucose metabolism in
skeletal muscle. The results show that individuals with a high level of
physical conditioning have greater insulin-stimulated IRS-1-associated
PI3-kinase activation in skeletal muscle during hyperinsulinemia. The
enhanced PI3-kinase activation is directly associated with augmented
insulin-mediated glucose disposal and
O2 max, both of which
are characteristic of physically fit individuals. Thus a key step in
the intracellular insulin signaling pathway is upregulated at a time
when insulin-mediated glucose transport by skeletal muscle is also
increased relative to sedentary control subjects. These results extend
our knowledge of the potential mechanisms that underlie
exercise-induced improvements in insulin-mediated glucose transport in
human skeletal muscle in vivo.
In our present study, the benefit of enhanced physical conditioning on insulin-mediated glucose uptake was evidenced by the greater rate of glucose disposal (31%) in skeletal muscle of the exercise trained vs. sedentary subjects. These data are consistent with the work of other investigators who have reported 20-30% differences in glucose uptake during hyperinsulinemia when comparing trained and untrained individuals (26, 34). Upregulation of the molecular steps in the insulin signaling pathway may play a primary role in facilitating the observed increase in insulin-mediated glucose uptake. Kim et al. (24) have shown that exercise training can bring about a significant increase in insulin receptor, IRS-1, and mitogen-activated protein kinase mRNA levels in murine skeletal muscle. In the present study, we examined PI3-kinase activation because it appears to be an important protein in the insulin signaling cascade. Furthermore, it has been shown that activation of PI3-kinase is essential for GLUT-4 translocation and insulin-mediated glucose uptake in skeletal muscle (31, 32). The relative importance of PI3-kinase as a regulatory step in the insulin signaling pathway is further underscored by data showing an association between decreased PI3-kinase activation and reduced glucose transport ability in studies using human and animal models of diabetes, insulin resistance, and obesity (4, 16, 20). To date, there are no data on the effects of exercise training on insulin-stimulated PI3-kinase activity in human skeletal muscle. However, Han et al. (18) have reported preliminary data showing increases in IRS-1-associated PI3-kinase activity in rats undergoing voluntary exercise on a running wheel. The present study provides the first evidence showing an increase in insulin activation of IRS-1-associated PI3-kinase activity in human skeletal muscle with regular exercise. On the basis of the combined data from human and animal models, it appears that the ability to upregulate PI3-kinase through a program of regular exercise may serve to facilitate greater insulin-mediated glucose uptake. These data provide evidence at the molecular level to support the efficacy of exercise as an intervention in the treatment of insulin resistance and Type 2 diabetes in humans.
The trained group in this study was comprised of individuals who
performed aerobic exercise on a regular basis and had been engaged in
sport for most of their life. The
O2 max of the trained group was significantly higher than their sedentary counterparts, and
correlation analysis revealed a significant positive relationship between
O2 max and
PI3-kinase activation. Therefore, our data suggest a strong link
between exercise capacity and the increased insulin signaling ability
of the muscle obtained from the trained group. It is possible that the
enhanced insulin action in the trained group may be due to elevated
protein expression of steps in the insulin signaling pathway. Due to
technical limitations, we were unable to measure PI3-kinase protein
expression. However, we did use equal amounts of protein in the assays
performed on muscle obtained from both groups. Thus, in the assay
performed under the same conditions of protein in vitro,
insulin-induced PI3-kinase activity is greater in the trained group.
Further work is required to determine if the observed increase in
PI3-kinase activity is accompanied by increased protein expression or
perhaps by changes in more proximal steps in the pathway, e.g.,
increased insulin receptor phosphorylation or increased tyrosine
phosphorylation of IRS-1.
Some of the metabolic adaptations associated with exercise training have been ascribed to the previous exercise session rather than long-term changes in metabolism. Measurements of insulin-mediated glucose uptake in trained subjects who have stopped exercising suggest that most of the exercise training effects are lost ~48 h after the cessation of exercise (25, 35). However, it has been shown that insulin-mediated leg glucose uptake rates are higher after 10 wk of exercise training than after a single exercise bout (10). Thus, whereas the effects of exercise may be transient, chronic exercise training appears to induce a physiological adaptation that augments insulin sensitivity in skeletal muscle. Furthermore, individuals who exercise regularly may maintain a higher metabolic rate, and this may help to sustain the benefits associated with exercise in a relatively permanent manner, assuming that the individual continues to perform exercise. In the present study, we performed our measurements of insulin-mediated glucose uptake and PI3-kinase activity ~18 h after the last exercise session for the trained group. Thus, whereas measurements made at this time may be influenced by the last exercise bout, it is perhaps more physiologically reflective of the insulin and metabolic milieu that is characteristic of individuals who exercise on a regular basis.
The effect of exercise training on insulin signaling in the present study should be distinguished from previous reports on the immediate effects of acute exercise on 1) specific steps in the insulin signaling pathway and 2) insulin stimulation of the insulin signaling pathway. There is no increase in insulin receptor autophosphorylation, tyrosine phosphorylation of the insulin receptor, or IRS-1 and PI3-kinase activation in human or animal muscle immediately after a single bout of exercise or after muscle contraction (16, 38, 40). Furthermore, it has been shown that muscle contraction can have a negative effect on insulin signaling and specifically on PI3-kinase activation in rat epitroclearis muscle (15). Data from our laboratory also show that, in well-trained athletes, an acute bout of intense cycling exercise to exhaustion causes a decrease in IRS-1-associated PI3-kinase for up to 30 min after the exercise bout (12). Likewise, insulin-stimulated IRS-1-associated PI3-kinase is also reduced in human skeletal muscle for up to 5 h after a single bout of exercise (40). In contrast, Zhou and Dohm (43) reported an increase in insulin-stimulated PI3-kinase activity in rat muscle after a single bout of treadmill running. These later findings raise interesting questions regarding the specific methodologies employed to immunoprecipitate PI3-kinase. Zhou and Dohm (43) used an anti-phosphotyrosine antibody, which immunoprecipitates both IRS-1- and IRS-2-associated PI3-kinase. We and others have immunoprecipitated only the IRS-1-associated isoform. After an acute bout of exercise, IRS-2-associated PI3-kinase may be increased in compensation for downregulation in the IRS-1-associated isoform. In contrast, exercise training brings about adaptations at the molecular level that include an increase in IRS-1-associated PI3-kinase. At this time, we do not know if there is also an increase in IRS-2-associated PI3-kinase. The reasons for the apparent conflicting observations between acute exercise and exercise training are unclear at present but may be related to competing biochemical and metabolic demands during the initial recovery from an acute bout of exercise as opposed to the relatively stable metabolic state that is present 12-18 h after the exercise session. The reason for the conflicting data on the effects of acute exercise on insulin-stimulated PI3-kinase may be related to activation of alternate signaling pathways, which have not been fully examined in studies to date. It remains to be determined whether these alternative insulin signaling pathways are downregulated by exercise or muscle contraction alone.
Apart from insulin receptor and/or postreceptor events, improved insulin-mediated glucose metabolism after exercise training could be determined by a prereceptor or a central adaptive response. Changes in hemodynamics leading to greater insulin and glucose delivery to the muscle have been noted when exercise is combined with insulin infusion (5, 8). Augmented basal and exercise-induced blood flow is a key adaptation associated with physical training. A significant relationship has been shown between basal limb blood flow and insulin-mediated glucose disposal in athletes (14). In addition, insulin transport across the capillary appears to be rate limiting for insulin action (36, 41). We did not see any significant differences in muscle capillary density in the trained vs. sedentary subjects, although the capillary-to-fiber ratio was ~56% higher (P = 0.07) in the trained group. The trend toward a potentially greater ability to perfuse the muscle in the trained group may have contributed to a slightly greater delivery of insulin to the receptor site on the plasma membrane of the muscle cell. However, our data are not conclusive on this point. Thus the effects of exercise training on the contribution of increased insulin and glucose delivery to the muscle and in turn overall increases in insulin-mediated glucose uptake remain to be determined.
In conclusion, the enhanced insulin sensitivity associated with exercise training appears to be mediated by increased postreceptor insulin signaling, specifically at the IRS-1-associated PI3-kinase step in the cascade that leads to GLUT-4 translocation and glucose uptake. These data strengthen the basis for recommending exercise as a therapeutic intervention that can directly improve insulin action on skeletal muscle among patients with insulin resistance and Type 2 diabetes. The present study also provides new and important data elucidating the molecular basis for the effects of physical conditioning on insulin action in human skeletal muscle.
| |
ACKNOWLEDGEMENTS |
|---|
We thank the nursing/dietary staff of the General Clinical Research Center for supporting the implementation of the study and assisting with data collection. We are also grateful to Dr. Andrea Dunaif for advice on the PI3-kinase assay and to Dr. Kevin Yarasheski for performing the glucose kinetics measurements.
| |
FOOTNOTES |
|---|
This research was supported by National Institute on Aging Grant AG-12834 (J. P. Kirwan), General Clinical Research Center Grant RR-10732 to the Pennsylvania State University, and Mass Spectrometry Resource Center Grant P41-RR-00959 to Washington University School of Medicine, St. Louis, MO.
Original submission in response to a special call for papers on "Molecular and Cellular Basis of Exercise Adaptations."
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: J. P. Kirwan, Case Western Reserve Univ. School of Medicine at MetroHealth Medical Center, Depts. of Reproductive Biology and Nutrition, Bell Greve Bldg., Rm G-231B, 2500 MetroHealth Drive, Cleveland, OH 44109-1998 (E-mail: jkirwan{at}metrohealth.org).
Received 9 September 1999; accepted in final form 1 November 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Akers, R.,
and
E. R. Buskirk.
An underwater system utilizing "force cube" transducers.
J. Appl. Physiol.
26:
649-652,
1969
2.
American Diabetes Association.
Screening for Type 2 diabetes.
Diabetes Care
22:
S20-S23,
1999.
3.
Andersen, P.
Capillary density in skeletal muscle of man.
Acta Physiol. Scand.
95:
203-205,
1975[ISI][Medline].
4.
Bjornholm, M.,
Y. Kawano,
M. Lehtihet,
and
J. R. Zierath.
Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation.
Diabetes
46:
524-527,
1997[Abstract].
5.
Bourey, R. E.,
A. R. Coggan,
W. M. Kohrt,
J. P. Kirwan,
D. S. King,
and
J. O. Holloszy.
Effect of exercise on glucose disposal: response to a maximal insulin stimulus.
J. Appl. Physiol.
69:
1689-1694,
1990
6.
Cheatham, B.,
C. J. Vlahos,
L. Cheatham,
L. Wang,
J. Blenis,
and
C. R. Kahn.
Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation.
Mol. Cell. Biol.
14:
4902-4911,
1994
7.
Clarke, J. F.,
P. W. Young,
K. Yonezawa,
M. Kasuga,
and
G. D. Holman.
Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin.
Biochem. J.
300:
631-635,
1994.
8.
DeFronzo, R. A.,
E. Ferrannini,
Y. Sato,
P. Felig,
and
J. Wahren.
Synergistic interaction between exercise and insulin on peripheral glucose uptake.
J. Clin. Invest.
68:
1468-1474,
1981.
9.
DeFronzo, R. A.,
J. D. Tobin,
and
R. Andres.
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
Am. J. Physiol. Endocrinol. Metab. Gastrointest. Physiol.
237:
E214-E223,
1979
10.
Dela, F.,
K. J. Mikines,
M. von Linstow,
N. H. Secher,
and
H. Galbo.
Effect of training on insulin mediated glucose uptake in human skeletal muscle.
Am. J. Physiol. Endocrinol. Metab.
263:
E1134-E1143,
1992.
11.
Dela, F.,
T. Ploug,
A. Handberg,
L. N. Petersen,
J. J. Larsen,
K. J. Mikines,
and
H. Galbo.
Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM.
Diabetes
43:
862-865,
1994[Abstract].
12.
Del Aguila, L. F.,
D. J. O'Gorman,
R. K. Krishnan,
and
J. P. Kirwan.
Acute exercise decreases insulin stimulation of phosphatidylinositol 3-kinase in human subjects (Abstract).
J. Sports Sci.
17:
570,
1999.
13.
Devlin, J.,
and
E. Horton.
Effects of prior high intensity exercise on glucose metabolism in normal and insulin resistant men.
Diabetes
34:
973-979,
1985[Abstract].
14.
Ebeling, P.,
R. Bourey,
L. Koranyi,
J. A. Tuominen,
L. C. Groop,
J. Henriksson,
M. Mueckler,
A. Sovijarvi,
and
V. A. Koivisto.
Mechanism of enhanced insulin sensitivity in athletes.
J. Clin. Invest.
92:
1623-1631,
1993.
15.
Goodyear, L. J.,
F. Giorgino,
T. W. Balon,
G. Condorelli,
and
R. J. Smith.
Effects of contractile activity on tyrosine phosphoproteins and PI 3-kinase activity in rat skeletal muscle.
Am. J. Physiol. Endocrinol. Metab.
268:
E987-E995,
1995
16.
Goodyear, L. J.,
F. Giorgino,
L. A. Sherman,
J. Carey,
R. J. Smith,
and
G. L. Dohm.
Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects.
J. Clin. Invest.
95:
2195-2204,
1995.
17.
Goodyear, L. J.,
L. F. Hirshman,
P. M. Valyou,
and
E. A. Horton.
Glucose transporter number, function and subcellular distribution in rat skeletal muscle after exercise training.
Diabetes
41:
1091-1099,
1992[Abstract].
18.
Han, D.-H.,
P. A. Hansen,
M. M. Chen,
and
J. O. Holloszy.
DHEA treatment reduces fat accumulation and protects against insulin resistance in male rats.
J. Gerontol.
53A:
B19-B24,
1998.
19.
Hayashi,
Tatsuya,
J. F. P. Wojtaszewski,
and
L. J. Goodyear.
Exercise regulation of glucose transport in skeletal muscle.
Am. J. Physiol. Endocrinol. Metab.
273:
E1039-E1051,
1997
20.
Heydrick, S. J.,
D. Jullien,
N. Gautier,
J. F. Tanti,
S. Giorgetti,
E. Van Obberghen,
and
Y. Marchand-Brustel.
Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice.
J. Clin. Invest.
91:
1358-1366,
1993.
21.
Hickey, M. S.,
C. J. Tanner,
S. O'Neill,
L. J. Morgan,
G. L. Dohm,
and
J. A. Houmard.
Insulin activation of phosphatidylinositol 3-kinase in human skeletal muscle in vivo.
J. Appl. Physiol.
83:
718-722,
1997
22.
Houmard, J. A.,
P. C. Egan,
P. D. Neufer,
J. E. Friedman,
W. S. Wheeler,
R. G. Israel,
and
G. L. Dohm.
Elevated skeletal muscle glucose transporter levels in exercise-trained middle- aged men.
Am. J. Physiol. Endocrinol. Metab.
261:
E437-E443,
1991
23.
Jahoor, F.,
E. J. Peters,
and
R. R. Wolfe.
The relationship between gluconeogenic substrate supply and glucose production in humans.
Am. J. Physiol. Endocrinol. Metab.
258:
E288-E296,
1990
24.
Kim, Y.,
T. Inoue,
R. Nakajima,
K. Nakae,
T. Tamura,
K. Tokuyama,
and
M. Suzuki.
Effects of endurance training on gene expression of insulin signal transduction pathway.
Biochem. Biophys. Res. Commun.
210:
766-773,
1995[ISI][Medline].
25.
King, D. S.,
G. P. Dalsky,
W. E. Clutter,
D. A. Young,
M. A. Staten,
P. E. Cryer,
and
J. O. Holloszy.
Effects of exercise and lack of exercise on insulin sensitivity and responsiveness.
J. Appl. Physiol.
64:
1942-1946,
1988
26.
King, D. S.,
G. P. Dalsky,
M. A. Staten,
W. E. Clutter,
D. R. Van Houten,
and
J. O. Holloszy.
Insulin action and secretion in endurance-trained and untrained humans.
J. Appl. Physiol.
63:
2247-2252,
1987
27.
Kirwan, J. P.,
R. C. Hickner,
K. E. Yarasheski,
W. M. Kohrt,
B. V. Wiethop,
and
J. O. Holloszy.
Eccentric exercise induces transient insulin resistance in healthy individuals.
J. Appl. Physiol.
72:
2197-2202,
1992
28.
Kirwan, J. P.,
D. O'Gorman,
and
W. J. Evans.
A moderate glycemic meal before endurance exercise can enhance performance.
J. Appl. Physiol.
84:
53-59,
1997
29.
Koivisto, V. A., H. Yki-Jarvinen, and R. A. DeFronzo. Physical training and insulin sensitivity. Diabetes
Metab. Rev. 1, 1986.
30.
Koval, J. A.,
R. A. DeFronzo,
R. M. O'Doherty,
R. Printz,
H. Ardehali,
D. K. Granner,
and
L. J. Mandarino.
Regulation of hexokinase II activity and expression in human muscle by moderate exercise.
Am. J. Physiol. Endocrinol. Metab.
274:
E304-E308,
1998
31.
Lee, A. D.,
P. A. Hansen,
and
J. O. Holloszy.
Wortmannin inhibits insulin-stimulated but not contraction-stimulated glucose transport activity in skeletal muscle.
FEBS Lett.
361:
51-54,
1995[ISI][Medline].
32.
Lund, S.,
G. D. Holman,
O. Schmitz,
and
O. Pedersen.
Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin.
Proc. Natl. Acad. Sci. USA
92:
5817-5821,
1995
33.
McQuire, E. A. H.,
J. H. Helderman,
J. D. Tobin,
R. Andres,
and
M. Berman.
Effects of arterial versus venous sampling on analysis of glucose kinetics in man.
J. Appl. Physiol.
41:
565-573,
1976
34.
Mikines, K. J.,
B. Sonne,
P. A. Farrell,
B. Tronier,
and
H. Galbo.
Effect of training on the dose-response relationship for insulin action in men.
J. Appl. Physiol.
66:
695-703,
1989
35.
Mikines, K. J.,
B. Sonne,
B. Tronier,
and
H. Galbo.
Effects of acute exercise and detraining on insulin action in trained men.
J. Appl. Physiol.
66:
704-711,
1988
36.
Poulin, R. A.,
G. M. Steil,
D. M. Moore,
M. Ader,
and
R. N. Bergman.
Dynamics of glucose production and uptake are more closely related to insulin in hindlimb lymph than in thoracic duct lymph.
Diabetes
43:
180-190,
1994[Abstract].
37.
Siri, W. E.
The gross composition of the body.
Adv. Biol. Med. Phys.
4:
239-280,
1956[Medline].
38.
Treadway, J. L.,
D. E. James,
E. Burcel,
and
N. B. Ruderman.
Effect of exercise on insulin receptor binding and kinase activity in skeletal muscle.
Am. J. Physiol. Endocrinol. Metab.
256:
E138-E144,
1989
39.
White, M. F.,
R. Maron,
and
C. R. Kahn.
Insulin rapidly stimulates tyrosine phosphorylation of a Mr 185,000 protein in intact cells.
Nature
318:
183-186,
1985[Medline].
40.
Wojtaszewski, J. F. P.,
B. F. Hansen,
B. Kiens,
and
E. A. Richter.
Insulin signaling in human skeletal muscle.
Diabetes
46:
1775-1781,
1997[Abstract].
41.
Yang, Y. J.,
I. D. Hope,
M. Ader,
and
R. N. Bergman.
Insulin transport across capillaries is rate limiting for insulin action in dogs.
J. Clin. Invest.
84:
1620-1628,
1989.
42.
Yeh, J. I.,
E. A. Gulve,
L. Rameh,
and
M. J. Birnbaum.
The effects of wortmannin on rat skeletal muscle. Dissociation of signaling pathways for insulin- and contraction-activated hexose transport.
J. Biol. Chem.
270:
2107-2111,
1995
43.
Zhou, Q.,
and
G. L. Dohm.
Treadmill running increases phospatidylinositol 3-kinase activity in rat skeletal muscle.
Biochem. Biophys. Res. Comm.
236:
647-650,
1997[ISI][Medline].
This article has been cited by other articles:
![]() |
M. J. Zhu, B. Han, J. Tong, C. Ma, J. M. Kimzey, K. R. Underwood, Y. Xiao, B. W. Hess, S. P. Ford, P. W. Nathanielsz, et al. AMP-activated protein kinase signalling pathways are down regulated and skeletal muscle development impaired in fetuses of obese, over-nourished sheep J. Physiol., May 15, 2008; 586(10): 2651 - 2664. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. J. Solomon, S. N. Sistrun, R. K. Krishnan, L. F. Del Aguila, C. M. Marchetti, S. M. O'Carroll, V. B. O'Leary, and J. P. Kirwan Exercise and diet enhance fat oxidation and reduce insulin resistance in older obese adults J Appl Physiol, May 1, 2008; 104(5): 1313 - 1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Friedman, J. P. Kirwan, M. Jing, L. Presley, and P. M. Catalano Increased Skeletal Muscle Tumor Necrosis Factor-{alpha} and Impaired Insulin Signaling Persist in Obese Women With Gestational Diabetes Mellitus 1 Year Postpartum Diabetes, March 1, 2008; 57(3): 606 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Frosig, A. J. Rose, J. T. Treebak, B. Kiens, E. A. Richter, and J. F.P. Wojtaszewski Effects of Endurance Exercise Training on Insulin Signaling in Human Skeletal Muscle: Interactions at the Level of Phosphatidylinositol 3-Kinase, Akt, and AS160 Diabetes, August 1, 2007; 56(8): 2093 - 2102. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Trout, C. Homko, and N. C. Tkacs Methods of Measuring Insulin Sensitivity Biol Res Nurs, April 1, 2007; 8(4): 305 - 318. [Abstract] [PDF] |
||||
![]() |
G. D. Wadley, N. Konstantopoulos, L. Macaulay, K. F. Howlett, A. Garnham, M. Hargreaves, and D. Cameron-Smith Increased insulin-stimulated Akt pSer473 and cytosolic SHP2 protein abundance in human skeletal muscle following acute exercise and short-term training J Appl Physiol, April 1, 2007; 102(4): 1624 - 1631. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Ferrara, A. P. Goldberg, H. K. Ortmeyer, and A. S. Ryan Effects of aerobic and resistive exercise training on glucose disposal and skeletal muscle metabolism in older men. J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2006; 61(5): 480 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Sigal, G. P. Kenny, D. H. Wasserman, and C. Castaneda-Sceppa Physical Activity/Exercise and Type 2 Diabetes Diabetes Care, October 1, 2004; 27(10): 2518 - 2539. [Full Text] [PDF] |
||||
![]() |
J. P. Kirwan, A. Varastehpour, M. Jing, L. Presley, J. Shao, J. E. Friedman, and P. M. Catalano Reversal of Insulin Resistance Postpartum Is Linked to Enhanced Skeletal Muscle Insulin Signaling J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4678 - 4684. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Perreault, J. M. Lavely, B. C. Bergman, and T. J. Horton Gender differences in insulin action after a single bout of exercise J Appl Physiol, September 1, 2004; 97(3): 1013 - 1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Krisan, D. E. Collins, A. M. Crain, C. C. Kwong, M. K. Singh, J. R. Bernard, and B. B. Yaspelkis III Resistance training enhances components of the insulin signaling cascade in normal and high-fat-fed rodent skeletal muscle J Appl Physiol, May 1, 2004; 96(5): 1691 - 1700. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jessen, R. Pold, E. S. Buhl, L. S. Jensen, O. Schmitz, and S. Lund Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles J Appl Physiol, April 1, 2003; 94(4): 1373 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Steensberg, C. Keller, R. L. Starkie, T. Osada, M. A. Febbraio, and B. K. Pedersen IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle Am J Physiol Endocrinol Metab, December 1, 2002; 283(6): E1272 - E1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Ho, K. P. Davy, M. S. Hickey, S. A. Summers, and C. L. Melby Behavioral, metabolic, and molecular correlates of lower insulin sensitivity in Mexican-Americans Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E799 - E808. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Zierath Exercise Effects of Muscle Insulin Signaling and Action: Invited Review: Exercise training-induced changes in insulin signaling in skeletal muscle J Appl Physiol, August 1, 2002; 93(2): 773 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Henriksen Exercise Effects of Muscle Insulin Signaling and Action: Invited Review: Effects of acute exercise and exercise training on insulin resistance J Appl Physiol, August 1, 2002; 93(2): 788 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. Christ, D. Hunt, J. Hancock, R. Garcia-Macedo, L. J. Mandarino, and J. L. Ivy Exercise training improves muscle insulin resistance but not insulin receptor signaling in obese Zucker rats J Appl Physiol, February 1, 2002; 92(2): 736 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Tanner, T. R. Koves, R. L. Cortright, W. J. Pories, Y.-B. Kim, B. B. Kahn, G. L. Dohm, and J. A. Houmard Effect of short-term exercise training on insulin-stimulated PI 3-kinase activity in middle-aged men Am J Physiol Endocrinol Metab, January 1, 2002; 282(1): E147 - E153. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yu, E. Blomstrand, A. V. Chibalin, H. Wallberg-Henriksson, J. R. Zierath, and A. Krook Exercise-associated differences in an array of proteins involved in signal transduction and glucose transport J Appl Physiol, January 1, 2001; 90(1): 29 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. O'Gorman, L. F. Del Aguila, D. L. Williamson, R. K. Krishnan, and J. P. Kirwan |